Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion
- 1 December 2000
- journal article
- Published by Elsevier in Kidney International
- Vol. 58 (6), 2341-2350
- https://doi.org/10.1046/j.1523-1755.2000.00418.x
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitusKidney International, 1992
- Heparan Sulfate Proteoglycans Are Lost in Patients with Diabetic NephropathyNephron, 1992
- Reduced number of anionic sites is associated with glomerular basement membrane thickening in the diabetic BB-ratDiabetologia, 1989
- Reduced content and abnormal distribution of anionic sites (acid proteoglycans) in the diabetic glomerular basement membraneVirchows Archiv B Cell Pathology Including Molecular Pathology, 1986
- Glomerular Proteoglycans in Diabetes: Partial Structural Characterization and Metabolism of De Novo Synthesized Heparan-35SO4 and Dermatan-35SO4 Proteoglycans in Streptozocin-Induced Diabetic RatsDiabetes, 1986
- The Stages in Diabetic Renal Disease: With Emphasis on the Stage of Incipient Diabetic NephropathyDiabetes, 1983
- Decreased de novo synthesis of glomerular proteoglycans in diabetes: biochemical and autoradiographic evidence.Proceedings of the National Academy of Sciences, 1983
- Effect of Diabetes on the Glycosaminoglycan Component of the Human Glomerular Basement MembraneDiabetes, 1982
- 35S-Glycosaminoglycan and 35S-Glycopeptide Metabolism by Diabetic Glomeruli and AortaDiabetes, 1982
- Genesis and evolution of diabetic nephropathy.Journal of Clinical Pathology, 1981